503b glp-1 🚨 FDA Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale compounding of medications like semaglutide and tirzepatide, signaling a major shift in how these Second 503B Facility SHUTS DOWN

Enriched with the power of Glutathione, this serum works tirelessly to combat dullness, dark spots, and uneven skin tone

A Japanese study discussed the safety and efficacy of oral SEMA 14 mg in patients with MASLD and T2DM

Plasma and tissue GSH levels decline with age, while markers of oxidative damage increase, creating a "redox imbalance" implicated in the pathogenesis of age-related diseases [2][3][10][11]

The rise of GLP-1 medications prescribed via telehealth, including tirzepatide (Mounjaro, Zepbound), semaglutide (Ozempic, Wegovy) and liraglutide (Saxenda), has produced positive results for many individuals

Saxenda (liraglutide, daily injection) sits in the same class but has largely been overtaken in clinical use by the weekly options